RenovaCare products are under development and not approved for sale in the United States.
Results may vary from person to person.

Presentations

Date

Title

Video

Transcript

Presentation

01/19/2021

Noble Capital Markets Annual Presentation

10/29/20

Investor Summit Presentation

Latest Press Releases

RenovaCare to Present at H.C. Wainwright Global Life Science Conference March 9-10, 2021

Roseland, NJ – February 25th, 2021 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that the Company will present at the 2021 H.C. Wainwright Global Life Sciences Conference, scheduled for March 9 – 10.

Read more

Company Overview

RenovaCare, Inc. is committed to the highest standards of ethical behavior and the Company’s commitment extends to all aspects of its role as an employer and as a corporate citizen. This commitment to ethical behavior extends beyond mere compliance with laws and regulations to inspire our relationships with our shareholders, clients, and employees.

Corporate Office:

RenovaCare, Inc.
4 Becker Farm Road, Suite 105
Roseland, New Jersey 07068
1-888-398-0202

Sign Up for Investor Alerts